Drug Discovery & Development
News on drug screening, clinical trials, companion diagnostics, immunotherapy, & personalized therapies in genetics, genomics, and molecular diagnostics.
Personalis Nabs $50M Investment From Merck, Extends Collaboration with Moderna
The company extended its collaboration to further advance an investigational personalized vaccine therapy under development by Merck and Moderna.
Guardant Health, Boehringer Ingelheim Partner on Companion Diagnostic for New Lung Cancer Drug
The companies aim to establish Guardant360 CDx as a tool to identify patients with HER2 mutations eligible for treatment with the targeted drug zongertinib.
The letter encourages drug developers to "further study and use" αSyn-SAA testing for selecting patients for clinical trials for Parkinson's and related diseases.
Nucleai to Integrate Predictive Biomarker Tech Into Proscia Digital Pathology Platform
The companies will integrate Nucleai's technologies into Proscia's cloud-based Concentriq digital pathology platform.
Angle to Develop Prostate Cancer Liquid Biopsy Assay for AstraZeneca
The company will use its Parsortix platform to develop a circulating tumor cell-based assay to measure androgen receptor status in therapy response.